Nicotinic Acetylcholine Receptor Modulation Distinguishes Clinical Benefits of Galantamine in Alzheimer’s Disease - Pavel V. Svintozelskiy; Andrew J. Wahlert; Carson Harrod; Denis G. Kay; Kurt P. Grady; George T. Grossberg (Sage Open Aging, 2026)